p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis

Oncogene

Volumn 23, Issue 3, 2004, Pages 687-696

  Gao, Jing ^a   Huang, Hong Ying ^b   Pak, Joanne ^a   Cheng, Jin ^b   Zhang, Zhong Ting ^b   Shapiro, Ellen ^b   Pellicer, Angel ^b   Sun, Tung Tien ^b   Wu, Xue Ru ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder cancer; Oncogene; p53; Ras; Suppressor gene; Tumor

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; UROPLAKIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER TUMOR; CARCINOGENESIS; CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DYSPLASIA; HETEROZYGOSITY; HYPERPLASIA; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSGENIC MOUSE; UROTHELIUM; WILD TYPE;

ANIMALS; BASE SEQUENCE; CELL DIVISION; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; GENES, P53; GENES, RAS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; URINARY BLADDER NEOPLASMS; UROTHELIUM;

ANIMALIA; MUS MUSCULUS;

EID: 1242318513     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207169     Document Type: Article

References (52)

1. Bowman T, Symonds H, Gu L, Yin C, Oren M and Van Dyke T. (1996). Genes Dev., 10, 826-835.
2. Brinster RL, Chen HY, Trumbauer M, Senear AW, Warren R and Palmiter RD. (1981). Cell, 27, 223-231.
3. Bryan TM and Reddel RR. (1994). Crit. Rev. Oncogol., 5, 331-357.
4. Chen PL, Chen YM, Bookstein R and Lee WH. (1990). Science, 250, 1576-1580.
5. Chene P. (2001). Oncogene, 20, 2611-2617.
6. Cheng J, Huang H, Pak J, Shapiro E, Sun TT, Cordon-Cardo C, Waldman FM and Wu XR. (2003). Cancer Res., 63, 179-185.
7. Cheng J, Huang H, Zhang ZT, Shapiro E, Pellicer A, Sun TT and Wu XR. (2002). Cancer Res., 62, 4157-4163.
8. Cordon-Cardo C, Cote RJ and Sauter G. (2000). Scand. J. Urol. Nephrol. Suppl., 205, 82-93.
9. Cordon-Cardo C, Dalbagni G, Sarkis AS and Reuter VE. (1994). Important Advances in Oncology. DeVita VT, Hellman S and Rosenberg SA (eds). Lippincott JB Company: Philadelphia, pp. 71-83.
10. Cordon-Cardo C and Sheinfeld J. (1997). World J. Urol., 15, 112-119.
11. Cordon-Cardo C, Sheinfeld J and Dalbagni G. (1997). Semin. Surg. Oncol., 13, 319-327.
12. Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG and Benedict WF. (1998). Cancer Res., 58, 1090-1094.
13. Czerniak B, Cohen GL, Etkind P, Deitch D, Simmons H, Herz F and Koss LG. (1992). Hum. Pathol., 23, 1199-1204.
14. Dahse R, Utting M, Werner W, Schubert J, Claussen U and Junker K. (2000). Oncol. Rep., 7, 931-936.
15. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
16. Ferbeyre G, de Stanchina E, Lin AW, Querido E, McCurrach ME, Hannon GJ and Lowe SW. (2002). Mol. Cell. Biol., 22, 3497-3508.
17. Fitzgerald JM, Ramchurren N, Rieger K, Levesque P, Silverman M, Libertino JA and Summerhayes IC. (1995). J. Natl. Cancer Inst., 87, 129-133.
18. Fradet Y and Lacombe L. (2000). Curr. Opin. Urol., 10, 441-445.
19. Frazier MW, He X, Wang J, Gu Z, Cleveland JL and Zambetti GP. (1998). Mol. Cell. Biol., 18, 3735-3743.
20. Gottifredi V, Shieh SY and Prives C. (2000). Cold Spring Harb. Symp. Quant. Biol., 65, 483-488.
21. Grossman HB, Liebert M, Antelo M, Dinney CP, Hu SX, Palmer JL and Benedict WF. (1998). Clin. Cancer Res., 4, 829-834.
22. Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Konishi M, Kawashima I, Takamoto S, Hirai H and Miyaki M. (1995). Oncogene, 11, 1339-1345.
23. Knowles MA. (1995). Br. J. Urol., 1, 57-66.
24. Knowles MA. (2001). Mol. Pathol., 54, 215-221.
25. Koss LG. (1992). J. Cell. Biochem. Suppl., 16I, 23-29.
26. Lacombe L, Dalbagni G, Zhang ZF, Cordon-Cardo C, Fair WR, Herr HW and Reuter VE. (1996). J. Clin. Oncol., 14, 2646-2652.
27. Lanyi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA and Deb S. (1998). Oncogene, 16, 3169-3176.
28. Levine AJ. (1997). Cell, 88, 323-331.
29. Liebert M and Seigne J. (1996). Semin. Urol. Oncol., 14, 62-72.
30. Lin JH, Zhao H and Sun TT. (1995). Proc. Natl. Acad. Sci. USA, 92, 679-683.
31. Llopis J, Alcaraz A, Ribal MJ, Sole M, Ventura PJ, Barranco MA, Rodriguez A, Corral JM and Carretero P. (2000). Eur. Urol., 37, 644-653.
32. Messing EM. (1992). Semin. Surg. Oncol., 8, 285-292.
33. Orntoft TF and Wolf H. (1998). Urol. Res., 26, 223-233.
34. Pohar KS and Cordon-Cardo C. (2002). Cancer Precursors, Franco EL and Rohan TE (eds). Springer-Verlag: New York, pp. 344-361.
35. Prenzel N, Fischer OM, Streit S, Hart S and Ullrich A. (2001). Endocr. Relat. Cancer, 8, 11-31.
36. Raghavan D. (2003). Cancer, 97, 2083-2089.
37. Reed M, Woelker B, Wang P, Wang Y, Anderson ME and Tegtmeyer P. (1995). Proc. Natl. Acad. Sci. USA, 92, 9455-9459.
38. Reiher F, Ozer O, Pins M, Jovanovic BD, Eggener S and Campbell SC. (2002). J. Urol., 167, 1469-1474.
39. Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Blelloch RH, Puthenveettil JA and Cuthill S. (1996). Semin. Oncol., 23, 571-584.
40. Sandberg AA and Berger CS. (1994). J. Urol., 151, 545-560.
41. Sarkis AS, Dalbagni G, Cordon-Cardo C, Melamed J, Zhang ZF, Sheinfeld J, Fair WR, Herr HW and Reuter VE. (1994). J. Urol., 152, 388-392.
42. Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW and Reuter VE. (1993). J. Natl. Cancer Inst., 85, 53-59.
43. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW. (1997). Cell, 88, 593-602.
44. Shaulian E, Zauberman A, Ginsberg D and Oren M. (1992). Mol. Cell. Biol., 12, 5581-5592.
45. Shaulsky G, Goldfinger N and Rotter V. (1991). Cancer Res., 51, 5232-5237.
46. Soussi T. (2000). Ann. NY Acad. Sci., 910, 121-137.
47. Spruck CHr, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote, R, Dubeau L, Nichols PW, Hermann GG, Steven K, Horn T, Skinner DG and Jones PA. (1994). Cancer Res., 54, 784-788.
48. Theodorescu D. (2003). Histol. Histopathol., 18, 259-274.
49. Vageli D, Kiaris H, Delakas D, Anezinis P, Cranidis A and Spandidos DA. (1996). Cancer Lett., 107, 241-247.
50. Zambetti GP, Olson D, Labow M and Levine AJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 3952-3956.
51. Zhang ZT, Pak J, Huang HY, Shapiro E, Sun TT, Pellicer A and Wu XR. (2001). Oncogene, 20, 1973-1980.
52. Zhang ZT, Pak J, Shapiro E, Sun TT and Wu XR. (1999). Cancer Res., 59, 3512-3517.